Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Post by BigWave1on Jan 14, 2016 12:13am
91 Views
Post# 24456725

News

NewsPretty quiet on this one......

Hope 2016 is the year of LDS.

Canna Delivery Systems Inc. Executes Letter of Intent to License Proprietary Technology Vancouver, British Columbia, Canada, January 6, 2016, Lifestyle Delivery Systems Inc. (CSE: LDS and OTCQB: LDSYF) (“LDS” or the “Company”) is pleased to announce that Canna Delivery Systems Inc. (“CDS”), the Company’s wholly owned subsidiary, has executed a non-binding letter of intent (“LOI”) to license its proprietary technology for producing dissolvable cannabis infused oral strips called “CannaStrips” to Wisdom Homes of America, Inc. (“WOFA”). The LOI contemplates that CDS will grant WOFA a non-exclusive license to manufacture and distribute CannaStrips in Northern California. It is expected that WOFA will pay CDS an annual license fee of $25,000 and that Canna will be the exclusive supplier to WOFA of all non-medicinal ingredients for CannaStrips. In addition, CDS will grant WOFA access to the CannaStrips brand, with an option to contract or sub-contract to cannabis producers and retailers throughout Northern California. Grant of the license rights remains conditional upon the negotiation and execution of definitive binding agreements. James Pakulis, the President of Lifestyle Delivery Systems Inc. and CEO of Wisdom Homes of America, Inc., stated: “We are excited for the opportunity to partner with Wisdom Homes of America and believe that the partnership with this company will allow CDS to successfully introduce its CannaStrips products to Northern California market.“
Bullboard Posts